
Cohu reported Q4 revenue of $122.2 million, roughly +30% year‑over‑year and in line with analyst expectations, but posted a non‑GAAP adjusted loss of $0.15 per share versus the Street’s modeled $0.06 per‑share profit, sending the stock down about 7.2% intraday. Management guided Q1 sales of $115 million to $129 million (roughly flat sequentially) and forecast gross margin around 45% versus 42.7% a year ago, and pegged full‑year high‑bandwidth‑memory (HBM) revenue at $15–$20 million, noting HBM growth could help margins going forward.
Market structure: COHU’s 30% revenue growth with an adjusted loss signals strong end-market demand but adverse mix/costs; winners are AI chipmakers and HBM suppliers (NVDA, HBM foundries) if HBM adoption rises, losers are small ATE/test-equipment names with tight cash flow. Pricing power is weak for COHU until gross margin stabilizes above ~45%; incremental HBM sales ($15–20M guidance) could shift mix but is <20% of a quarter’s revenue, so limited immediate share gains. Risk assessment: Near-term (days–weeks) expect volatility and IV elevation; short-term (1–3 quarters) risk centers on continued margin misses and inventory build in customers; long-term (≥12 months) upside hinges on sustained HBM ramps tied to NVDA-led AI capex. Tail risks: sudden loss of a top-3 customer, supply-chain disruption, or a contract win that materially exceeds $20M (positive). Key hidden dependency: COHU’s profitability is levered to HBM unit economics and customers’ fab timelines. Trade implications: Direct play — short COHU size-managed (2–3% NAV) or buy a 3-month 10%/20% OTM put spread to limit downside; pair trade — long NVDA (1–2% NAV) vs short COHU (1% NAV) to express AI demand over niche test equipment. Rotate 2–4% away from small-cap semiconductor equipment into large-cap AI/semiconductor leaders (NVDA, SOXX), and use a 25–40% downside target on COHU with a hard stop at +15% loss. Contrarian angles: The selloff may be overdone if management hits guidance: margin improvement to ≥45% next quarter and HBM >$20M could trigger a rapid re-rating, so keep positions size-limited and use spreads. Historical precedent: ATE suppliers have gapped down on misses then rebounded on order reacceleration; thus watch the next 60-day order/intake signal and avoid outright conviction until one positive or negative quarter confirms the trend.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment